Patton Albertson Miller Group LLC Trims Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Patton Albertson Miller Group LLC lessened its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 3.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,508 shares of the medical instruments supplier’s stock after selling 505 shares during the period. Patton Albertson Miller Group LLC’s holdings in DENTSPLY SIRONA were worth $552,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of XRAY. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in DENTSPLY SIRONA by 132.4% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 83,817 shares of the medical instruments supplier’s stock worth $2,863,000 after purchasing an additional 47,748 shares during the period. Strs Ohio raised its stake in DENTSPLY SIRONA by 14.6% during the third quarter. Strs Ohio now owns 47,167 shares of the medical instruments supplier’s stock valued at $1,611,000 after buying an additional 6,021 shares during the last quarter. IFM Investors Pty Ltd boosted its holdings in DENTSPLY SIRONA by 5.3% in the third quarter. IFM Investors Pty Ltd now owns 40,372 shares of the medical instruments supplier’s stock worth $1,379,000 after acquiring an additional 2,047 shares in the last quarter. Park Avenue Securities LLC purchased a new stake in shares of DENTSPLY SIRONA in the third quarter worth $313,000. Finally, Cambiar Investors LLC increased its holdings in shares of DENTSPLY SIRONA by 3.0% during the third quarter. Cambiar Investors LLC now owns 280,747 shares of the medical instruments supplier’s stock valued at $9,590,000 after acquiring an additional 8,201 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

Shares of XRAY traded up $0.39 during trading hours on Thursday, hitting $28.20. The stock had a trading volume of 5,078,023 shares, compared to its average volume of 3,392,529. DENTSPLY SIRONA Inc. has a 12 month low of $26.27 and a 12 month high of $41.65. The stock has a fifty day moving average price of $31.71 and a 200 day moving average price of $32.60. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.43 and a quick ratio of 0.97. The firm has a market capitalization of $5.86 billion, a PE ratio of -64.09, a PEG ratio of 1.24 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, meeting the consensus estimate of $0.42. The firm had revenue of $953.00 million during the quarter, compared to analyst estimates of $969.45 million. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The business’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.39 EPS. Analysts anticipate that DENTSPLY SIRONA Inc. will post 2.03 EPS for the current year.

DENTSPLY SIRONA Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were given a dividend of $0.16 per share. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. The ex-dividend date of this dividend was Wednesday, March 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.27%. DENTSPLY SIRONA’s payout ratio is presently -145.45%.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on XRAY shares. StockNews.com cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, May 3rd. Robert W. Baird reduced their price target on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating for the company in a research report on Friday, May 3rd. SVB Leerink started coverage on DENTSPLY SIRONA in a research report on Monday, February 26th. They issued an “outperform” rating and a $42.00 price objective on the stock. Piper Sandler reissued a “neutral” rating and issued a $32.00 target price (down previously from $35.00) on shares of DENTSPLY SIRONA in a report on Friday, May 3rd. Finally, The Goldman Sachs Group lowered their price target on DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating on the stock in a report on Monday. Five analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $35.22.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.